Hormonal acne in adult women responds to anti-androgenic therapy. Choice depends on PCOS context.
Adult-onset / persistent acne in women with predominantly jawline + chin distribution is typically androgen-mediated. PCOS is a common underlying driver.
Ages 20-40, often with oily skin / cycle-linked flares. PCOS phenotypes more affected.
All options below are real published treatments. Evidence-level reflects current clinical guidelines (NAMS / ACOG / Endocrine Society). Cost ranges are starting price estimates from $US public sources.
Monthly cost
$5-$50
Side effects
nausea, mood changes
Drospirenone-containing OCPs (Yaz, Yasmin) are first-line. Onset ~3 months. Plus dual benefit of cycle regulation.
Providers offering this: pandia health, tia womens health
Monthly cost
$10-$30 generic
Side effects
hyperkalemia (lab monitoring), menstrual irregularity, breast tenderness
Off-label dermatologic use. Reduces androgen signaling in skin. Dose 50-200mg daily. Onset ~3 months.
Contraindications: Hyperkalemia, renal impairment, pregnancy
Providers offering this: allara, pollie pcos specialist
Monthly cost
$10-$80
Side effects
skin irritation, photosensitivity
Always combine with systemic therapy for hormonal acne. Standalone topical insufficient for moderate/severe cases.
Yes, frequently combined to maximize anti-androgen effect. OCPs also prevent pregnancy (spironolactone is contraindicated in pregnancy due to anti-androgen effect on male fetus).
Last verified 2026-06-01. Treatment guidelines update — confirm with your clinician.